ArticleCancer discovery2024
Next Directions in the Neuroscience of Cancers Arising outside the CNS.
Abstract read
In one paragraph
Article in Cancer discovery, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 22 papers.
0numbers the graph read from it
0cells of the map it votes in
22citing papers in PubMed
–field-weighted citation impact
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
22 citing papers in PubMed.
- Nociceptor neurons suppress antitumor immunity in breast cancer.Research square · 2026Article
- Sex influences on tumor innervation.Biology of sex differences · 2026Article
- Article
- A public data-based molecular classification of small cell lung cancer by neuroactive signaling networks unveils distinct microenvironment landscapes and immunotherapy-related prognostic biomarkers.Translational lung cancer research · 2025Article
- β-adrenergic signaling blockade attenuates metastasis through activation of cytotoxic CD4 T cells.Nature communications · 2025Article
- A brain cancer microtissue model for studying tumor cell and neural cell interactions.Scientific reports · 2025Article
- Review
- Hijacking homeostasis: the brain-body neural circuitry in tumor pathogenesis and emerging therapeutic frontiers.Molecular cancer · 2025Review
- Sympathetic axonogenesis promotes adenoid cystic carcinoma progression.The Journal of experimental medicine · 2025Article
- Cancer and neurotransmitter receptors.Chinese medical journal · 2025Review
- Tumor-infiltrating nerves: unraveling the role of cancer neuroscience in tumorigenesis, disease progression, and emerging therapies.Discover oncology · 2025Review
- The Sunrise of Tertiary Lymphoid Structures in Cancer.Immunological reviews · 2025Review
- Advancing Neurosurgical Oncology and AI Innovations in Latin American Brain Cancer Care: Insights from a Center of Excellence.NeuroSci · 2025Review
- The regulation of reporter transgene expression for diverse biological imaging applications.Npj imaging · 2025Review
- Hijacking of the nervous system in cancer: mechanism and therapeutic targets.Molecular cancer · 2025Review
- The metabolic basis of cancer-related fatigue.Neuroscience and biobehavioral reviews · 2025Review
- Integrating priorities at the intersection of cancer and neuroscience.Cancer cell · 2025Article
- The Case for Neurosurgical Intervention in Cancer Neuroscience.Neurosurgery · 2025Review
- Vagus nerve stimulation: Novel concept for the treatment of glioblastoma and solid cancers by cytokine (interleukin-6) reduction, attenuating the SASP, enhancing tumor immunity.Brain, behavior, & immunity - health · 2024Review
- Cancer neuroscience at the brain-body interface.Genes & development · 2024Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
29 authors.
Moran AmitDepartment of Head and Neck Surgery, The University of Texas MD Anderson Cancer Center, Houston, Texas.ORCID 0000-0002-9720-7766
Corina AnastasakiDepartment of Neurology, Washington University, St. Louis, Missouri.ORCID 0000-0002-9928-6488
Robert DantzerDepartment of Symptom Research, The University of Texas MD Anderson Cancer Center Houston, Texas.ORCID 0000-0001-9399-6107
Ihsan Ekin DemirDepartment of Surgery, Klinikum rechts der Isar, Technical University of Munich, Germany; Neural Influences in Cancer (NIC) International Research Consortium, Munich, Germany.ORCID 0000-0001-8241-1871
Benjamin DeneenCenter for Cancer Neuroscience and Center for Cell and Gene Therapy, Baylor College of Medicine, Houston, Texas.ORCID 0000-0002-6335-1081
Karen O DixonDepartment of Biomedicine, University of Basel, Basel, Switzerland.ORCID 0000-0001-7811-5439
Mikala EgebladDepartments of Cell Biology and Oncology, Johns Hopkins University School of Medicine, Baltimore, Maryland.ORCID 0000-0002-3371-1445
Erin M GibsonDepartment of Psychiatry and Behavioral Sciences, Stanford University School of Medicine, Palo Alto, California.ORCID 0000-0001-9749-3814
Shawn L Hervey-JumperDepartment of Neurological Surgery and Weill Neuroscience Institute, University of California, San Francisco, San Francisco, California.ORCID 0000-0003-4699-260X
Hubert HondermarckCancer Neuroscience Laboratory, Hunter Medical Research Institute, School of Biomedical Sciences and Pharmacy, The University of Newcastle, Callaghan NSW 2308, Australia.ORCID 0000-0003-3807-2985
Claire MagnonLaboratory of Cancer and Microenvironment-National Institute of Health and Medical Research (INSERM), Institute of Biology François Jacob-Atomic Energy Commission (CEA), University of Paris Cité, University of Paris-Saclay, Paris, France.ORCID 0000-0003-2946-5269
Michelle MonjeDepartment of Neurology and Neurological Sciences, Stanford University, Stanford, California.ORCID 0000-0002-3547-237X
Shorook Na'araDepartment of Head and Neck Surgery, The University of Texas MD Anderson Cancer Center, Houston, Texas.ORCID 0000-0003-2633-5864
Yuan PanDepartment of Symptom Research, The University of Texas MD Anderson Cancer Center Houston, Texas.ORCID 0000-0002-9465-8289
Elizabeth A RepaskyDepartment of Immunology, Roswell Park Comprehensive Cancer Center, Buffalo, New York.ORCID 0000-0002-9554-4152
Nicole N ScheffHillman Cancer Center, Department of Neurobiology, University of Pittsburgh, Pittsburgh, Pennsylvania.ORCID 0000-0002-5587-4990
Erica K SloanDrug Discovery Biology Theme, Monash Institute of Pharmaceutical Sciences, Monash University, Parkville Victoria, Australia.ORCID 0000-0002-2355-1433
Sebastien TalbotDepartment of Biomedical and Molecular Sciences, Queen's University, Kingston, Ontario, Canada.ORCID 0000-0001-9932-7174
Kevin J TraceyThe Feinstein Institutes for Medical Research, Northwell Health, Manhasset, New York.ORCID 0000-0003-1884-6314
Lloyd C TrotmanCold Spring Harbor Laboratory, Cold Spring Harbor, New York.ORCID 0000-0002-4794-1559
Manuel ValienteBrain Metastasis Group, Spanish National Cancer Research Centre (CNIO), Madrid, Spain.ORCID 0000-0002-0647-7542
Linda Van AelstCold Spring Harbor Laboratory, Cold Spring Harbor, New York.ORCID 0000-0002-0870-012X
Varun VenkataramaniNeurology Clinic and National Center for Tumor Diseases, University Hospital Heidelberg, Heidelberg, Germany; Clinical Cooperation Unit Neurooncology, German Cancer Research Center, Heidelberg, Germany.ORCID 0000-0002-2927-0886
Humsa S VenkateshDepartment of Neurology, Brigham and Women's Hospital, Boston, Massachusetts.ORCID 0000-0003-1194-3015
Paola D VermeerCancer Biology and Immunotherapies Group, Sanford Research, Sioux Falls, South Dakota.ORCID 0000-0003-2370-8223
Frank WinklerNeurology Clinic and National Center for Tumor Diseases, University Hospital Heidelberg, Heidelberg, Germany; Clinical Cooperation Unit Neurooncology, German Cancer Research Center, Heidelberg, Germany.ORCID 0000-0003-4892-6104
Richard J WongDepartment of Head and Neck Surgery and Oncology, Memorial Sloan Kettering Cancer Center, New York, New York.ORCID 0000-0001-6259-7314
David H GutmannDepartment of Neurology, Washington University, St. Louis, Missouri.ORCID 0000-0002-3127-5045
Jeremy C BornigerCold Spring Harbor Laboratory, Cold Spring Harbor, New York.ORCID 0000-0002-5419-0271
Funding
Single-Cell Biology Shared ResourceP30CA045508 · NCI · COLD SPRING HARBOR LABORATORY · PI John Edward Moses · 1987 to 2026
$118.9MTargeting the Vasular SystemP50CA165962 · NCI · MASSACHUSETTS GENERAL HOSPITAL · PI KEITH LLOYD LIGON · 2013 to 2026
$33.5MMolecular Basis of Bioelectronic MedicineR35GM118182 · NIGMS · FEINSTEIN INSTITUTE FOR MEDICAL RESEARCH · PI TRACEY, KEVIN J · 2016 to 2025
$7.3MTargeting the neuronal microenvironment in glioblastomaU19CA264504 · NCI · BRIGHAM AND WOMEN'S HOSPITAL · PI Tracy T Batchelor · 2021 to 2026
$6.4MPilot Project ProgramP30GM145398 · NIGMS · SANFORD RESEARCH/USD · PI W KEITH MISKIMINS · 2023 to 2026
$6.2MDefining the Mechanistic Basis for Neurofibromatosis-1 Nervous System Disease HeterogeneityR35NS097211 · NINDS · WASHINGTON UNIVERSITY · PI GUTMANN, DAVID H · 2017 to 2024
$5.7MThe Metabolic Basis of Cancer-Related FatigueR01CA193522 · NCI · UNIVERSITY OF TX MD ANDERSON CAN CTR · PI DANTZER, ROBERT · 2015 to 2023
$3.8MAstrocyte Transcriptional Dependencies in Brain CircuitsR35NS132230 · NINDS · BAYLOR COLLEGE OF MEDICINE · PI Benjamin Deneen · 2023 to 2026
$3.5MNeuronal Regulation of Low-Grade GliomagenesisR01CA258384 · NCI · STANFORD UNIVERSITY · PI David H Gutmann, Michelle Monje-Deisseroth · 2022 to 2026
$3.1MMetastasis of PTEN Mutant Prostate CancerR01CA275128 · NCI · COLD SPRING HARBOR LABORATORY · PI TROTMAN, LLOYD C · 2022 to 2025
$2.7MIdentifying the pro-metastatic mechanisms of neutrophil extracellular trapsR01CA237413 · NCI · JOHNS HOPKINS UNIVERSITY · PI EGEBLAD, MIKALA · 2020 to 2024
$2.6MTranscriptional Regulation in ZFTA-RELA EpendymomaR01CA284455 · NCI · ST. JUDE CHILDREN'S RESEARCH HOSPITAL · PI Benjamin Deneen, Stephen C Mack · 2023 to 2026
$2.5MNCI NIH HHS P30 CA045508NCI NIH HHS P50 CA165962NCI NIH HHS R01 CA193522NCI NIH HHS R01 CA237413NCI NIH HHS R01 CA258384NCI NIH HHS R01 CA261939NCI NIH HHS R01 CA275128NCI NIH HHS R01 CA284455NCI NIH HHS R01 CA286651NCI NIH HHS R21 CA267135NCI NIH HHS R21 CA282866NCI NIH HHS U19 CA264504NIDCR NIH HHS R01 DE030892NIDCR NIH HHS R01 DE032712NIGMS NIH HHS P30 GM145398NIGMS NIH HHS R35 GM118182NINDS NIH HHS K08 NS110919NINDS NIH HHS R01 NS124093NINDS NIH HHS R21 NS130712NINDS NIH HHS R35 NS097211NINDS NIH HHS R35 NS132230
Abstract
summaryThe field of cancer neuroscience has begun to define the contributions of nerves to cancer initiation and progression; here, we highlight the future directions of basic and translational cancer neuroscience for malignancies arising outside of the central nervous system.
Indexed as
NeoplasmsNeurosciencesCentral Nervous SystemForecastingHumansProteomics
Identifiers
What OpenQuestion holds
Textmetadata
LicenceTDM
Read underepoch 390
Registered trials
None linked
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.